Tag: Ascentage Pharma

Innovent Biologics’ olverembatinib gets Chinese breakthrough therapy status in SDH-deficient GIST

businessnewstoday- June 3, 2023

Innovent Biologics has been granted breakthrough therapy designation (BTD) for olverembatinib from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA). ... Read More

Ascentage Pharma gets FDA ODD for APG-2575 in Waldenström macroglobulinemia

pharmanewsdaily- July 16, 2020

Ascentage Pharma has been granted orphan drug designation (ODD) for its Bcl-2 inhibitor APG-2575 from the US Food and Drug Administration (FDA) for the treatment ... Read More

Ascentage, Acerta to evaluate APG-2575, CALQUENCE combo in r/r CLL/SLL

pharmanewsdaily- June 22, 2020

Ascentage Pharma has entered into a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca to assess the combination ... Read More